| Financial Year |
March 31 2023 |
| Monetary Funds |
1,740,413,110.71 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
363,444,274.46 |
| Accounts Receivable |
3,437,833,114.42 |
| Advances to Suppliers |
61,973,281.25 |
| Other Receivables |
72,691,092.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
474,209,665.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
30,062,882.06 |
| Other Current Assets |
70,682,754.41 |
| Total Current Assets |
6,833,872,053.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
172,563,534.79 |
| Long-term Equity Investment |
15,521,206.19 |
| Investment Properties |
12,652,258.40 |
| Fixed Assetes |
989,908,017.85 |
| Under-construction Projects |
9,560,138.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
464,779,636.72 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
238,917,538.52 |
| Other Non-Current Assets |
308,431.76 |
| Sub-Total of Non-Current Assets |
1,904,510,763.00 |
| Total Assets |
8,738,382,816.24 |
| Short-Term Loans |
1,053,450,649.99 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,670,154,593.88 |
| Accounts Payable |
1,537,890,144.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
101,059,014.07 |
| Taxes Payable |
11,966,023.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
785,247,795.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,855,425.21 |
| Other Current Liabilities |
197,350,585.58 |
| Sub-Total of Current Liabilities |
5,630,452,273.75 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
141,442,670.31 |
| Deferred Income Tax Liabilities |
13,984,995.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
425,025,705.21 |
| Total Liabilities |
6,055,477,978.96 |
| Paid-In Capital(Or Share Stock) |
592,903,936.00 |
| Capital Surplus |
477,528,747.58 |
| Surplus Reserve |
224,530,945.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,313,217,410.01 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,682,904,837.28 |
| Owner's Equity（Stockholder's Equity） |
2,682,904,837.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,738,382,816.24 |
